Print

Series B financing round of NovaShunt AG

09.03.2011
NovaShunt AG raises CHF 23.7 Mio. in a Series B financing co-led by BioMedInvest II LP.

NovaShunt_PR Announcement for Series B Final.pdf
57 kB

© BioMedPartners 2007top